首页> Molecular therapy : the journal of the American Society of Gene Therapy> Tumor-Resident Dendritic Cells and Macrophages Modulate the Accumulation of TCR-Engineered T Cells in Melanoma.

Tumor-Resident Dendritic Cells and Macrophages Modulate the Accumulation of TCR-Engineered T Cells in Melanoma.

导出 OA

翻译打印收藏纠错

第一作者： Alastair,Hotblack

第一单位： Institute for Immunity and Transplantation, Division of Infection and Immunity, University College London, London NW3 2PF, UK.

作者： Alastair,Hotblack ^[1] ; Angelika,Holler ^[1] ; Alice,Piapi ^[1] ; Sophie,Ward ^[2] ; Hans J,Stauss ^[3] ; Clare L,Bennett ^[4]

作者单位： Institute for Immunity and Transplantation, Division of Infection and Immunity, University College London, London NW3 2PF, UK. ^[1] Institute for Immunity and Transplantation, Division of Infection and Immunity, University College London, London NW3 2PF, UK; Cancer Institute, Division of Cancer Studies, University College London, London WC1E 6DD, UK. ^[2] Institute for Immunity and Transplantation, Division of Infection and Immunity, University College London, London NW3 2PF, UK. Electronic address: h.stauss@ucl.ac.uk. ^[3] Institute for Immunity and Transplantation, Division of Infection and Immunity, University College London, London NW3 2PF, UK; Cancer Institute, Division of Cancer Studies, University College London, London WC1E 6DD, UK. Electronic address: c.bennett@ucl.ac.uk. ^[4]

关键词 adoptive cellular therapy dendritic cells engineered T?cells myeloid cells tumor